J P Hosker - Concepedia

Concepedia

Author

J P Hosker

Oxford Centre for Diabetes, Endocrinology and Metabolism

Also Known As

J HOSKER, J P Hosker, J. Hosker, J. P. Hosker, J.P Hosker, J.P. Hosker, JP Hosker, T. Hashmi

23

Publications

31.8K

Citations

11

H-Index

19

Concepts

All Affiliations

Oxford Centre for Diabetes, Endocrinology and Metabolism Manchester Royal Infirmary

JP

About

J P Hosker is an author at Oxford Centre for Diabetes, Endocrinology and Metabolism specializing in diabetes, metabolic syndrome, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	31.6K
2	Health Sciences	6	6	31.6K
3	Biochemistry	2	2	39
4	Biomedical Engineering	1	1	286
5	Biostatistics	1	1	27

J P Hosker

×

11

Publications

31.8K

Citations

11

H-Index

	Year	Citations
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man David R. Matthews, J P Hosker, A. Rudenski, Diabetologia Insulin ResistanceObesityMetabolic SyndromeBody CompositionHealth Sciences	1985	31K
Continuous infusion of glucose with model assessment: measurement of insulin resistance and ?-cell function in man J P Hosker, David R. Matthews, A. Rudenski, Diabetologia Insulin ResistanceMetabolic SyndromeDiabetes ManagementBody CompositionInsulin Management	1985	286
BETA-CELL DYSFUNCTION, RATHER THAN INSULIN INSENSITIVITY, IS THE PRIMARY DEFECT IN FAMILIAL TYPE 2 DIABETES Stephen O’Rahilly, A. Rudenski, M. A. Burnett, The Lancet ObesityMetabolic SyndromeInsulin ResistanceDiabetesPathology	1986	233
Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism Sudhesh Kumar, A O Olukoga, Caroline Gordon, Clinical Endocrinology	1994	115
Sulphonylurea therapy doubles B-cell response to glucose in Type 2 diabetic patients J P Hosker, M. A. Burnett, Eleanor Davies, Diabetologia Metabolic SyndromeDiabetes ManagementSulphonylurea TherapyMedicineInsulin Management	1985	48
Does adding fibre to a low energy, high carbohydrate, low fat diet confer any benefit to the management of newly diagnosed overweight type II diabetics? V. Beattie, C. A. Edwards, J P Hosker, BMJ	1988	37
Application of structural model of glucose-insulin relations to assess beta-cell function and insulin sensitivity. R. C. Turner, A. Rudenski, David R. Matthews, PubMed Insulin SignalingObesityMetabolic SyndromeBody CompositionSteady State	1990	27
Transient, selective factor X deficiency and acute liver failure following chest infection treated with erythromycin BP J P Hosker, D P Jewell Postgraduate Medical Journal	1983	20
INSULIN TREATMENT OF NEWLY-PRESENTING KETOTIC DIABETIC PATIENTS INTO THE HONEYMOON PERIOD J P Hosker The Lancet Diabetes ManagementInsulin TreatmentInsulin ManagementDiabetesDiabetes Mellitus	1982	14
Pancreatic islet amyloid and elevated proinsulin secretion in familial maturity-onset diabetes. Anne Clark, Dianne Matthews, B A Naylor, PubMed Metabolic SyndromeFamilial Maturity-onset DiabetesInsulin ManagementDiabetesImmunology	1987	14

Page 1